These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30957954)

  • 81. AZD5213: a novel histamine H3 receptor antagonist permitting high daytime and low nocturnal H3 receptor occupancy, a PET study in human subjects.
    Jucaite A; Takano A; Boström E; Jostell KG; Stenkrona P; Halldin C; Segerdahl M; Nyberg S
    Int J Neuropsychopharmacol; 2013 Jul; 16(6):1231-9. PubMed ID: 23217964
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Discovery of Potential, Dual-Active Histamine H
    Kuder KJ; Kotańska M; Szczepańska K; Mika K; Reiner-Link D; Stark H; Kieć-Kononowicz K
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33921144
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The Histamine H3 Receptor: Structure, Pharmacology, and Function.
    Nieto-Alamilla G; Márquez-Gómez R; García-Gálvez AM; Morales-Figueroa GE; Arias-Montaño JA
    Mol Pharmacol; 2016 Nov; 90(5):649-673. PubMed ID: 27563055
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Synthesis, structure-activity relationships, and biological profiles of a quinazolinone class of histamine H3 receptor inverse agonists.
    Nagase T; Mizutani T; Ishikawa S; Sekino E; Sasaki T; Fujimura T; Ito S; Mitobe Y; Miyamoto Y; Yoshimoto R; Tanaka T; Ishihara A; Takenaga N; Tokita S; Fukami T; Sato N
    J Med Chem; 2008 Aug; 51(15):4780-9. PubMed ID: 18598020
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pharmacokinetic and pharmacodynamic assessment of histamine H
    Kimura Y; Takahata K; Shimazaki T; Kitamura S; Seki C; Ikoma Y; Ichise M; Kawamura K; Yamada M; Zhang MR; Higuchi M; Nishino I; Suhara T
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1127-1135. PubMed ID: 34651222
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Synthesis, characterization, and biological assessment of the four stereoisomers of the H(3) receptor antagonist 5-fluoro-2-methyl-N-[2-methyl-4-(2-methyl[1,3']bipyrrolidinyl-1'-yl)phenyl]benzamide.
    Gao Z; Hurst WJ; Guillot E; Nagorny R; Pruniaux MP; Hendrix JA; George PG
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4044-7. PubMed ID: 23769643
    [TBL] [Abstract][Full Text] [Related]  

  • 87. QSAR Modeling of Histamine H3R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases.
    Correa MF; Dos Santos Fernandes JP
    Curr Neuropharmacol; 2018; 16(6):749-757. PubMed ID: 28820054
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Acute alertness-promoting effects of a novel histamine subtype-3 receptor inverse agonist in healthy sleep-deprived male volunteers.
    Iannone R; Palcza J; Renger JJ; Calder N; Cerchio K; Gottesdiener K; Hargreaves R; Dijk DJ; Boyle J; Murphy MG
    Clin Pharmacol Ther; 2010 Dec; 88(6):831-9. PubMed ID: 20981000
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs.
    Zhang M; Ballard ME; Pan L; Roberts S; Faghih R; Cowart M; Esbenshade TA; Fox GB; Decker MW; Hancock AA; Rueter LE
    Brain Res; 2005 May; 1045(1-2):142-9. PubMed ID: 15910772
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders.
    Passani MB; Lin JS; Hancock A; Crochet S; Blandina P
    Trends Pharmacol Sci; 2004 Dec; 25(12):618-25. PubMed ID: 15530639
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Structural requirements for inverse agonism and neutral antagonism of indole-, benzimidazole-, and thienopyrrole-derived histamine H4 receptor ligands.
    Schneider EH; Strasser A; Thurmond RL; Seifert R
    J Pharmacol Exp Ther; 2010 Aug; 334(2):513-21. PubMed ID: 20484153
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Recent medicinal chemistry of the histamine H3 receptor.
    Letavic MA; Barbier AJ; Dvorak CA; Carruthers NI
    Prog Med Chem; 2006; 44():181-206. PubMed ID: 16697898
    [No Abstract]   [Full Text] [Related]  

  • 93. Recent advances in histamine H3 receptor antagonists/inverse agonists.
    Łazewska D; Kieć-Kononowicz K
    Expert Opin Ther Pat; 2010 Sep; 20(9):1147-69. PubMed ID: 20716022
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A Photoswitchable Agonist for the Histamine H
    Hauwert NJ; Mocking TAM; Da Costa Pereira D; Lion K; Huppelschoten Y; Vischer HF; De Esch IJP; Wijtmans M; Leurs R
    Angew Chem Int Ed Engl; 2019 Mar; 58(14):4531-4535. PubMed ID: 30735597
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Discovery and Preclinical Validation of [(11)C]AZ13153556, a Novel Probe for the Histamine Type 3 Receptor.
    Schou M; Varnäs K; Jureus A; Ahlgren C; Malmquist J; Häggkvist J; Tari L; Wesolowski SS; Throner SR; Brown DG; Nilsson M; Johnström P; Finnema SJ; Nakao R; Amini N; Takano A; Farde L
    ACS Chem Neurosci; 2016 Feb; 7(2):177-84. PubMed ID: 26529287
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A qualitative model for the histamine H3 receptor explaining agonistic and antagonistic activity simultaneously.
    de Esch IJ; Timmerman H; Menge WM; Nederkoorn PH
    Arch Pharm (Weinheim); 2000 Aug; 333(8):254-60. PubMed ID: 11008375
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The naturally occurring mutation Y197C does not affect the expression or signaling of the human histamine H
    Flores-Clemente C; Escamilla-Sánchez J; Arias JM; Arias-Montaño JA
    Neurosci Lett; 2017 Feb; 641():77-80. PubMed ID: 28126588
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Constitutive activity of the histamine H3 receptor.
    Arrang JM; Morisset S; Gbahou F
    Trends Pharmacol Sci; 2007 Jul; 28(7):350-7. PubMed ID: 17573125
    [TBL] [Abstract][Full Text] [Related]  

  • 99. JNJ10181457, a histamine H3 receptor inverse agonist, regulates in vivo microglial functions and improves depression-like behaviours in mice.
    Iida T; Yoshikawa T; Kárpáti A; Matsuzawa T; Kitano H; Mogi A; Harada R; Naganuma F; Nakamura T; Yanai K
    Biochem Biophys Res Commun; 2017 Jul; 488(3):534-540. PubMed ID: 28526411
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [The histamine H3 receptor: a new target for the treatment of arousal and cognitive disorders].
    Arrang JM
    Ann Pharm Fr; 2007 Jul; 65(4):275-84. PubMed ID: 17652997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.